Outpatient Parenteral Antibiotic Therapy (OPAT) in the United States: Delivery models and indications for use

Canadian Journal of Infectious Diseases

Volumn 11, Issue SUPPL. A, 2000, Pages

  Tice, Alan D ^a  

^a Infectious Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001942051     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/676915     Document Type: Article

References (71)

1. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974;54:358-60.
2. Winters RW. Home infusion therapy industry: an overview. In: Conners RB, Winters RW, eds. Home Infusion Therapy: Current Status and Future Trends. Chicago: American Hospital Publishing Inc, 1995:1-15.
3. Liebert L, Bryant-Wimp J. Ambulatory infusion centers: hospital survival in an outpatient world. Infusion 1997;4:25-9.
4. Nolet BR. Complement or competition? Ambulatory infusion centers are redefining the patient pool for home infusion. Home Health Care 1998;January/February, 72-9.
5. Tice AD. The team concept. Hosp Pract 1993;28(Suppl 1):6-10.
6. Tice AD. Handbook of Outpatient Parenteral Therapy for Infectious Diseases. New York: Scientific American Inc, 1997.
7. Tice AD, Nolet BR. Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient Parenteral Antimicrobial Therapy: Current Status. New York: Scientific American Inc, 1997:7-11.
8. Tice AD. Intravenous access. In: Handbook of Outpatient Parenteral Therapy for Infectious Diseases. New York: Scientific American Inc, 1997:59-73.
9. Tice AD. Infusion devices. In: Handbook of Outpatient Parenteral Therapy for Infectious Diseases. New York: Scientific American Inc, 1997:75-82.
10. Craig WA. Selecting the antibiotic. Hosp Pract 1993;28(Suppl 1):16-20.
11. Tice AD. Antimicrobial selection for outpatient parenteral antibiotic therapy. In: Handbook of Outpatient Parenteral Therapy for Infectious Diseases. New York: Scientific American Inc, 1997:43-57.
12. Bradley JS. Once-daily ceftriaxone in the outpatient treatment of paediatric infections. Chemotherapy 1991;37(Suppl 3):3-6.
13. Poretz DM, Woolard D, Eron LJ, Goldenberg RI, Rising J, Sparks S. Outpatient use of ceftriaxone: a cost-benefit analysis. Am J Med 1984;77:77-83.
14. Tice AD. Osteomyelitis. Hosp Pract 1991;26:31-6.
15. MacGowan AP, Bowker KE. Pharmacodynamics of antimicrobial agents and rationale for their dosing. J Chemother 1997;9:64-73.
16. Craig WA. Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapy. Int J Antimicrob Agents 1995;5:19-22.
17. Luke DR, Foulds G, Cohen SF, Levy B. Safety, toleration, and pharmacokinetics of intravenous azithromycin. Antimicrob Agents Chemother 1996;40:2577-81.
18. Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med 1997;157:1421-8.
19. Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J Antimicrob Chemother 1995;36:385-94.
20. Mallet L. Age-related changes in renal function and clinical implications for drug therapy. J Geriatric Drug Therapy 1991;5:5-29.
21. Cooper JW. Anti-infective infusion therapy in the geriatric patient. Infusion 1997;3:10-9.
22. Livornese LL, Benz RL, Ingerman MJ, Santoro J. Antibacterial agents in renal failure. Infect Dis Clin North Am 1995;9:591-614.
23. Gross R, Graziani AL, Laufer D. Adverse effects of the use of intravenous pentamidine in the home. Infect Dis Clin Pract 1996;5:456-8.
24. McKinley GF. OPAT in the setting of HIV infection. In: Outpatient Parenteral Antimicrobial Therapy: Current Status New York: Scientific American Inc. 1997;77-80.
25. Sanborn GE, Anand R, Torti RE, et al. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device. Arch Ophthalmol 1992;110:188-95.
26. Jacobson MA, O'Donnell JJ, Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrobial Agents Chemother 1989;33:736-41.
27. Cundy KC, Petty BG, Flaherty J, et al. Clinical pharmokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1995;39:1247-52.
28. Polis MA, Spooner KM, Baird BF, et al. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrobial Agents Chemother 1995;39:882-6.
29. Tice AD. Osteomyelitis. In: Outpatient Parenteral Antimicrobial Therapy: Current Status. New York; Scientific American Inc, 1997;55-9.
30. Kunkel MJ. Outpatient treatment of endocarditis. In: Outpatient Parenteral Antimicrobial Therapy: Current Status. New York: Scientific American Inc, 1997;60-4.
31. Fine MJ, Chowdhry T, Ketema A. Outpatient management of community-acquired pneumonia. Hosp Pract 1998;June 15:123-33.
32. Powers RD. The role of the emergency department in OPAT. In: Outpatient Parenteral Antimicrobial Therapy: Current Status. New York: Scientific American Inc, 1997;28-31.
33. Noble WC. Skin and soft-tissue infections. Curr Opin Infect Dis 1996;9:57
34. Poretz DM. Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. Am J Med 1994;97:23-7.
35. Stiver HG, Trosky SK, Cote DD, et al. Self-administration of IV antibiotics: an efficient cost-effective home care program. CMAJ 1982;127:207-11.
36. Williams D. Home intravenous antibiotic therapy (HIVAT): indications, patients and antimicrobial agents. Int J Antimicrob Agents 1995;5:3-8.
37. Tice AD. Alternate site infusion: the physician-directed, office-based model. J Intraven Nurs 1996;19:188-93.
38. Tice AD. Infections amenable to outpatient parenteral antimicrobial therapy. In: Handbook of Outpatient Parenteral Therapy for Infectious Diseases. New York: Scientific American Inc, 1997:27-41.
39. Stamboulian D. Outpatient treatment of endocarditis in a clinic-based program in Argentina. Eur J Clin Micro Infect Dis 1995;14:648-54.
40. Tice AD. An office model of outpatient parenteral antibiotic therapy. Rev Infect Dis 1991;13(Suppl 2):184-8.
41. Bradley JS, Ching DK, Phillips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J 1988;7:160-4.
42. Plotkin SA. Treatment of bacterial meningitis. Pediatrics 1988;81:904-7.
43. Tice AD, Strait K, Ramey R, Hoaglund PA. Outpatient parenteral antimicrobial therapy for central nervous system infections. Clin Infect Dis 1999;29:1394-99.
44. Stiver HG, Telford GO, Mossey JM, et al. Intravenous antibiotic therapy at home. Ann Intern Med 1978;89:690-3.
45. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 1992;267:264-7.
46. Stamboulian D, Bonvehi D, Arevalo C, et al. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 1991;13(Suppl 2):160-3.
47. Durack D. Endocarditis. Hosp Pract 1993;28(Suppl 2):6-9.
48. Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy: a safe and effective alternative to inpatient care. Med J Aust 1995;162:249-53.
49. Conte RR. Home infusion therapy: treatment of cellutlitis. US Pharmacists Supplement 1994;Oct:9-11.
50. Kind AC, Williams DN, Gibson J. Outpatient intravenous antibiotic therapy. Ten years' experience. Postgrad Med 1985;77:105-8,111.
51. Lindbeck G, Powers R. Cellulitis. Hosp Pract 1993;28(Suppl 2):10-4.
52. Powers RD. Infections of skin and soft tissue. In: Outpatient Parenteral Antimicrobial Therapy: Current Status. New York: Scientific American Inc, 1997;65-8.
53. Deery II HG. Outpatient parenteral anti-infective therapy for skin and soft-tissue infections. Infect Dis Clin North Am 1998;12:935-49.
54. Poretz DM, Eron LJ, Goldenberg RI, et al. Intravenous antibiotic therapy in an outpatient setting. JAMA 1982;248:336-9.
55. Dalovisio JR. OPAT for community-acquired pneumonia. In: Outpatient Parenteral Antimicrobial Therapy: Current Status. New York: Scientific American Inc, 1997;69-72.
56. Williams DN. Reducing hospital costs and stay for pneumonia with home intravenous cefotaxime treatment: results with a computerized ambulatory drug delivery system. Am J Med 1994;27(Suppl 2A):50-5.
57. Tice AD. Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA. Eur J Clin Micro Infect Dis 1995;14:23-9.
58. Montalto M. How safe is hospital-in-the-home care? Med J Aust 1998;168:277-80.
59. Poretz DM. The infusion center: a model for outpatient parenteral antibiotic therapy. Rev Infect Dis 1991;13 (Suppl 2):142-6.
60. Hindes R, Winkler C, Kane P, Kunkel M. Outpatient intravenous antibiotic therapy in Medicare patients: cost-savings analysis. Infect Dis Clin Pract 1995;4:211-7.
61. Poretz DM. Outpatient parenteral antibiotic therapy. Int J Antimicrob Agents 1995;5:9-12.
62. Norden C, Gillespie WJ, Nade S. Vertebral osteomyelitis and disk space infection. In: Norden C, Gillespie WJ, Nade S, eds. Infections in bones and joints. Boston: Blackwell Scientific Publications, 1998:231-48.
63. Kayley J, Berendt AR, Snelling MJM, et al. Safe intravenous antibiotic therapy at home: experience of a UK based program. J Antimicrob Chemother 1996;37:1023-9.
64. Fox HR, Karchmer AW. Management of diabetic foot infections, including the use of home intravenous antibiotic therapy. Clin Podiatr Med Surg 1996;13:671-82.
65. Norden CW. Bone and joint infection. Curr Opin Inf Dis 1996;9:109-14.
66. Green SL. Practical guidelines for developing an office-based program for outpatient intravenous therapy. Rev Infect Dis 1991;13(Suppl 2):189-92.
67. Williams DN. Home intravenous antibiotic therapy. Int J Antimicrob Agents 1992;1:253-8.
68. Craig WA. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA. Eur J Clin Micro Infect Dis 1995;14:4-10.
69. Lim P. Enhancing care with home infusion. Can Nurs J 1995;91:53-5.
70. Yeung KT, Chan M, Chan CK. The safety of i.v. pentamidine administered in an ambulatory setting. Chest 1996;110:136-40.
71. Laufer D, Gross R, Graziani AA, MacGregor R. Use of intravenous pentamidine in the home. IDSA 31st Annual Meeting. New Orleans, October 16 to 18, 1993. (Abst)